Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongxinluo Capsule in Cerebral Small Vessel Disease
NCT06061692Phase 4Not yet recruiting
- Sponsor
- Fudan University
- Start
- Oct 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of Tongxinluo in Cerebral Small Vessel Disease (CSVD) (2 arms), sponsored by Fudan University. Primary endpoint: Vascular Dementia Cognitive Assessment Scale at 1 year. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
Tongxinluo
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on NCT06061692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06061692.